Epidermal growth factor receptor as a biomarker for cervical cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidermal growth factor receptor as a biomarker for cervical cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 22, Issue 10, Pages 2166-2178
Publisher
Oxford University Press (OUP)
Online
2011-02-17
DOI
10.1093/annonc/mdq723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients
- (2010) Linda Hertlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium
- (2010) Takeshi Maruo et al. CANCER
- Lack in Efficacy for Imatinib Mesylate as Second-Line Treatment of Recurrent or Metastatic Cervical Cancer Expressing Platelet-Derived Growth Factor Receptor α
- (2010) Myrna Candelaria et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
- (2009) Adhemar Longatto-Filho et al. BMC CANCER
- Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
- (2009) D D Meira et al. BRITISH JOURNAL OF CANCER
- Novel chemotherapy approaches for cervical cancer
- (2009) Sujana Movva et al. CANCER
- Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
- (2009) M. G. Noordhuis et al. CLINICAL CANCER RESEARCH
- Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
- (2009) Fernando Rivera et al. Expert Review of Anticancer Therapy
- Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
- (2009) J.E. Kurtz et al. GYNECOLOGIC ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer
- (2009) José Pérez-Regadera et al. ONCOLOGY
- EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: Implications for targeted radiotherapy
- (2008) Li Shen et al. BMC CANCER
- Epidermal growth factor receptor-targeted therapy
- (2008) C M West et al. BRITISH JOURNAL OF RADIOLOGY
- Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer
- (2008) A. Nogueira-Rodrigues et al. CLINICAL CANCER RESEARCH
- Correlation Among Six Biologic Factors (p53, p21WAF1, MIB-1, EGFR, HER2, and Bcl-2) and Clinical Outcomes After Curative Chemoradiation Therapy in Squamous Cell Cervical Cancer
- (2008) Hideomi Yamashita et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines
- (2008) M. Eiblmaier et al. JOURNAL OF NUCLEAR MEDICINE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
- Absence of epidermal growth factor receptor mutations in cervical cancer
- (2007) H. ARIAS-PULIDO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started